Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03249792 |
Title | Study of MK-2118 Administered as Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab (MK-3475) in the Treatment of Adults With Advance/Metastatic Solid Tumors or Lymphomas (MK-2118-001) |
Recruitment | Terminated |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Merck Sharp & Dohme Corp. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | ISR |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of California San Diego Moores Cancer Center ( Site 0004) | La Jolla | California | 92093 | United States | Details | |
UCLA ( Site 0003) | Los Angeles | California | 90095 | United States | Details | |
University of Chicago ( Site 0002) | Chicago | Illinois | 60637 | United States | Details | |
New York Presbyterian Hospital/Columbia University ( Site 0001) | New York | New York | 10032 | United States | Details | |
UPMC Hillman Cancer Centers ( Site 0007) | Pittsburgh | Pennsylvania | 15232 | United States | Details | |
Mary Crowley Cancer Research Center ( Site 0005) | Dallas | Texas | 75230 | United States | Details | |
MD Anderson Cancer Centr. ( Site 0006) | Houston | Texas | 77030 | United States | Details | |
Sheba Medical Center ( Site 0301) | Ramat-Gan | 5265601 | Israel | Details |